Related Experiment Video

Updated: Oct 7, 2025

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
04:30

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Published on: February 4, 2021

3.5K

Pathogenesis and Molecular Immune Mechanism of Calcified Aortic Valve Disease

Weikang Bian1, Zhicheng Wang1, Chongxiu Sun2

  • 1Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

Frontiers in Cardiovascular Medicine
|January 10, 2022
PubMed

Insights

Calcified aortic valve disease (CAVD) is an active inflammatory process, not passive degeneration. Understanding its pathogenesis offers new therapeutic targets and treatments like transcatheter aortic valve implantation (TAVI).

Area of Science:

  • Cardiovascular Biology
  • Pathology
  • Biomedical Engineering

Background:

  • Calcified aortic valve disease (CAVD) was traditionally viewed as passive degeneration.
  • Emerging evidence reveals CAVD as an active, complex process involving inflammation, endothelial injury, and matrix remodeling.
  • CAVD leads to aortic valve thickening, stenosis, and hemodynamic dysfunction, contributing significantly to cardiovascular mortality.

Purpose of the Study:

  • To summarize the current understanding of CAVD pathogenesis.
  • To explore novel therapeutic targets for delaying or blocking CAVD progression.
  • To discuss future directions in CAVD diagnosis and treatment, including transcatheter aortic valve implantation (TAVI).

Main Methods:

  • Review of recent scientific literature on CAVD pathogenesis.
  • Analysis of cellular and molecular mechanisms underlying CAVD.
  • Evaluation of current and emerging treatment strategies for CAVD.

Main Results:

  • CAVD involves active biological processes including inflammation, endothelial injury, matrix remodeling, and neovascularization.
  • Ectopic calcification on the aortic valve causes thickening, stenosis, and hemodynamic issues.
  • New therapeutic targets and interventions like TAVI are emerging for CAVD management.

Conclusions:

  • CAVD is an active, multifaceted disease process.
  • Targeting these active pathways holds promise for CAVD prevention and treatment.
  • Advances in understanding and treatment, such as TAVI, offer improved patient outcomes.

Keywords:
aortic stenosiscalcified aortic valve diseaseinflammationmatrix remodelingosteogenesis

More Related Videos

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro05:47

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

Published on: May 10, 2021

4.2K
Isolation of Human Primary Valve Cells for In vitro Disease Modeling07:31

Isolation of Human Primary Valve Cells for In vitro Disease Modeling

Published on: April 16, 2021

2.9K

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
76
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
78
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
155
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
67
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
80
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
63